2018 Update: How to Write Effective SOPs for FDA inspection & Regulatory Compliance - Webinar

  • ID: 4629731
  • Webinar
  • 27 November 2018 10:00 PST
  • 90 Minutes
  • World Compliance Seminar
1 of 5
Includes All the Training Handouts, Certificate by the Speaker, Q/A and 90 Min Live Webinar

Virtually every FDA inspection includes a review of SOPs and adverse agency findings are often the result of SOP administration issues.

Standard Operating Procedures (SOPs) are required by law for companies that are regulated by the Code of Federal Regulations such as Title 21 and Title 493. Yet there is no guidance on how to write, organize and maintain SOPs. Consequently, SOPs are frequently written in a way that makes compliance difficult or downright impossible. Worse, this often leads to many regulatory errors that first come to light during an FDA audit.

This webinar will show you how to write, organize, and maintain SOPs and train personnel in a way that will ensure compliance in a way that is concise, reproducible and easy to follow.

Why Should you attend:

This webinar will instruct the participant on how to write, organize, and maintain SOPs and train personnel in a way that will ensure compliance in a way that is concise, reproducible and easy to follow. It will begin with a strategic view of SOPs in a company and how SOPs can help streamline operations in addition to ensuring regulatory compliance. This will be followed by an explanation on how to get from regulations to the SOP. Finally, Best Practices for creating, implementing and maintaining SOPs using a risk-based approach and getting SOPs ready for inspection will be presented.

Note: Product cover images may vary from those shown
2 of 5

Areas Covered

  • SOPs and their relation to the regulations
  • SOPs as part of the company's regulatory infrastructure
  • SOP on SOPs and how to ensure conciseness, consistency and ease of use
  • Risk Based approach on SOP Best Practices for creation and maintenance
  • Training on SOPs
  • Tools for SOP tracking and when is validation required
  • What the FDA looks for in SOPs during an inspection
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Angela Bazigos Ms Angela Bazigos,
    CEO ,
    Touchstone Technologies Silicon Valley


    Angela Bazigos.CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers. Positions include Chief Compliance Officer at Morf Media. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA. Patent on speeding up software compliance. Recently quoted in Wall Street Journal for using training to bring regulatory compliance to the Boardroom. National Trainer for Society of Quality Assurance. Comments / collaborates with FDA on new guidance documents. Former President of Pacific Regional Chapter of Society of Quality Assurance. Stanford’s Who’s Who for Life Sciences.

Note: Product cover images may vary from those shown
5 of 5
  • Regulatory VP
  • Quality VPs
  • IT VPs
  • Regulatory Affairs professionals
  • Quality Managers
  • Quality Engineers
  • Small business owners
  • GxP
  • Consultants

Industries who can attend

All FDA industries:

  • MD
  • Pharma
  • Biotech
  • Food
  • Cosmetics
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll